Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Text2MD
AddedFeb 18, 2024
UpdatedJun 18, 2026
Text2MD

Text2MD

Seed

Text2MD: Affordable, high-quality telemedicine services for urgent, primary, and functional care.

HQ
Chicago, IL, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

Founded to revolutionize healthcare accessibility, Text2MD is a virtual healthcare platform offering a range of telemedicine services, including urgent care, primary care, and functional medicine. Their core mission is to provide affordable, high-quality medical care through a user-friendly digital interface, making healthcare accessible anytime and anywhere. The platform focuses on delivering immediate medical consultations and treatments via text, catering to patients seeking convenient and efficient healthcare solutions.

Text2MD has garnered attention for its innovative approach to telemedicine, attracting notable healthcare professionals and investors committed to advancing digital health. The platform's key achievements include a growing user base and positive patient reviews, highlighting its impact on improving healthcare accessibility and convenience. By leveraging technology to connect patients with doctors seamlessly, Text2MD is making significant strides in the telehealth industry, ensuring that quality medical care is just a text away.

Text2MD - Similar Companies

MD Integrations logo

MD Integrations

mdintegrations.com

MyTelemedicine logo

MyTelemedicine

mytelemedicine.com

CirrusMD logo

CirrusMD

cirrusmd.com

RemoteDoc logo

RemoteDoc

Akos MD logo

Akos MD

akosmd.com

GuruMD logo

GuruMD

EZaccessMD logo

EZaccessMD

ezaccessmd.com

OnMed logo

OnMed

onmed.com

Qapsula logo

Qapsula

qapsula.com

TeleMedicX logo

TeleMedicX

telemedicx.com

SteadyMD logo

SteadyMD

steadymd.com

AmplifyMD logo

AmplifyMD

amplifymd.com

DrAvailable logo

DrAvailable

Mdcapsule logo

Mdcapsule

ConnectMD logo

ConnectMD

Text2MD - Quick Facts

Who are Text2MD's competitors?

Companies similar to Text2MD include MD Integrations, MyTelemedicine, CirrusMD and RemoteDoc.

When was Text2MD founded?

Text2MD was founded in 2020.

Where is Text2MD's headquarters located?

Text2MD's headquarters is located in Chicago, IL, US.

When was Text2MD's last funding round?

Text2MD's most recent funding round was for $250k (USD) in December 2022.

How much has Text2MD raised to-date?

As of Dec 20, 2022, Text2MD has raised a total of $250k (USD).

How many employees does Text2MD have?

Text2MD has 5 employees as of Feb 4, 2024.

Text2MD - Classification

Ownership
  • Private
Technology
  • Telemedicine
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • SaaS
Customer
  • Consumers
Main Product
  • Healthcare
  • Telemedicine
Tags
  • Healthtech
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
Show 9 more industry codes
NAICS
  • 621000Ambulatory Health Care Services
  • 621600Home Health Care Services
  • 621610Home Health Care Services
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
SIC
  • 8060Hospitals
  • 8080Home Health Care Services
  • 8082Home Health Care Services